Press release
Ovarian Cancer Market 2024-2031 Global Industry Analysis, Size, Share, Growth, Trends, and Forecast | AstraZeneca, Roche, GlaxoSmithKline
Ovarian Cancer Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/ovarian-cancer-market
What is the projected growth of the Global Ovarian Cancer market?
Global Ovarian Cancer Market reached US$ 1.8 billion in 2022 and is expected to reach US$ 8.2 billion by 2031 growing with a CAGR of 23.7% during the forecast period 2024-2031.
What is Ovarian Cancer Market?
Ovarian cancer is a malignant tumor that originates in the ovaries, often developing without early symptoms, making it challenging to detect in its initial stages. It is one of the most serious gynecological cancers, commonly spreading to the pelvis and abdomen before diagnosis. Risk factors include genetic mutations (such as BRCA1 and BRCA2), family history, age, and hormonal influences. Treatment typically involves surgery, chemotherapy, targeted therapy, and, in some cases, immunotherapy. Early detection through screening in high-risk individuals can improve outcomes.
Who are the major players in the Ovarian Cancer market?
The prominent players in Ovarian Cancer market research report are: AstraZeneca, Roche, GlaxoSmithKline, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Celgene, Amgen, Pfizer, and Merck. The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.
Key Development
In January 2023, TYVYT® was added to the NRDL for gastric and esophageal cancer, making it the only PD-1 inhibitor for gastric cancer and first-line treatment of five major cancer types in the NRDL.
In November 2022, ImmunoGen received FDA approval for ELAHERE (mirvetuximab soravtansine-gynx) to treat FRα-positive platinum-resistant ovarian cancer, addressing a critical unmet need.
That same month, Roche's VENTANA FOLR1 RxDx Assay became the first IHC-based companion diagnostic approved by the FDA to identify ovarian cancer patients eligible for ELAHERE.
Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/ovarian-cancer-market
Market Segments
By Type: Epithelial ovarian cancer, Germ cell ovarian cancer, Stromal cell ovarian cancer, Small cell ovarian cancer
By Treatment Type: Diagnosis, Drug/Therapy
By End-user: Hospitals and Clinics, Cancer Centers, Others
The Ovarian Cancer industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Regions Covered:
The global Ovarian Cancer Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/ovarian-cancer-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ovarian Cancer Market 2024-2031 Global Industry Analysis, Size, Share, Growth, Trends, and Forecast | AstraZeneca, Roche, GlaxoSmithKline here
News-ID: 3884550 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Translucent Concrete Market 2025: Industry Developments, Future Gr …
Translucent Concrete Market is expected to grow at a CAGR of 51.5% during the forecast period 2024-2031
According to DataM Intelligence Comprehensive Report has released its latest report on the "Translucent Concrete Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build…
North America Immersion Cooling Market: Sub-1.0 PUE & Energy Efficiency Imperati …
Leander, Texas and TOKYO
North America Immersion Cooling Market is experienced to reach growth at a significant during the forecast period (2025-2032)
According to DataM Intelligence Comprehensive Report has released its latest report on the "North America Immersion Cooling Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help…
Overactive Bladder Treatment Market Growing at 3.6% CAGR During 2024-2031 | Agin …
Leander, Texas and Tokyo, Japan - Nov 17, 2025
The global overactive bladder treatment market is growing at a CAGR of 3.6% during the forecast period 2024-2031, driven by the increasing aging population susceptible to bladder control issues, rising prevalence of neurological disorders, growing patient awareness about treatment options, and ongoing innovations in minimally invasive therapies and pharmaceutical interventions for improved quality of life.
Get a Free Sample PDF Of…
Continuous Renal Replacement Therapy Market 2024-2031 | Increasing Acute Kidney …
Leander, Texas and Tokyo, Japan - Nov 17, 2025
The global continuous renal replacement therapy market is growing at a high CAGR during the forecast period 2024-2031, driven by the rising incidence of acute kidney injury in critically ill patients, increasing adoption in intensive care units, technological advancements in CRRT systems, a growing elderly population susceptible to renal complications, and expanding applications in multi-organ failure management and sepsis treatment.
Get…
More Releases for Ovarian
Ovarian Cancer Diagnostics Market Size: 2033 Statistics
The Ovarian Cancer Diagnostics market is expected to grow from an estimated USD 4814.5 million in 2024 to USD 7795.1 million in 2033, at a CAGR of 5.50%.
The ovarian cancer diagnostics market plays a critical role in the early detection and management of ovarian cancer, one of the most common and lethal gynecological cancers worldwide. Ovarian cancer is often diagnosed at an advanced stage due to the lack of noticeable…
Ovarian Cancer Market Size, Future Trends
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Ovarian Cancer Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Polycystic Ovarian Syndrome Treatment Market Report
The findings reviewed by GME stated that the Global Polycystic Ovarian Syndrome Treatment Market will expand with a CAGR value of 5.2 percent from 2021 to 2026. The rising incidence of PCOS increased understanding among a group of patients, and the growing acceptance of standard treatment boosts the PCOS treatment industry growth over the projected timeframe. Furthermore, the research and development of PCOS are predicted to aid in market growth.
Browse…
How deadly is Ovarian Cancer?
Ovarian Drugs and Treatment Market describes its growth, size, share, Forecast and trends to 2025
Ovarian cancer is a cancer that forms in or on an ovary. It results in abnormal cells that have the ability to invade or spread to other parts of the body.
The global Ovarian Cancer Treatment Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025,…
Polycystic Ovarian Syndrome Treatment Market - Regional Analysis
The organic and inorganic strategies by the market players will boost the polycystic ovarian syndrome treatment market. For instance, in 2016, Millendo Therapeutics, Inc., a biopharmaceutical company, entered into an exclusive license agreement with AstraZeneca for the development and commercialization of phase II entered AZD4901, a candidate product for the treatment of polycystic ovarian syndrome. Moreover, in 2017, Astellas Pharma Inc. completed its acquisition of Ogeda SA (formerly Euroscreen S.A.).…
Ovarian Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Ovarian Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Ovarian Cancer (OC) is the fifth most common malignancy diagnosed in women, and the most common gynecological cancer, with an estimated 225,000 new cases diagnosed globally in 2008. Rates are particularly high in developed countries, and especially in Northern Europe. However, substantial improvements in…
